131 related articles for article (PubMed ID: 37981553)
1. Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Different survival, similar recurrence: Report of a large study on repurposed databases with propensity score matching.
Amory B; Goumard C; Laurent A; Langella S; Cherqui D; Salame E; Barbier L; Soubrane O; Farges O; Hobeika C; Kawai T; Regimbeau JM; Faitot F; Pessaux P; Truant S; Boleslawski E; Herrero A; Mabrut JY; Chiche L; Di Martino M; Rhaiem R; Schwarz L; Resende V; Calderaro J; Augustin J; Caruso S; Sommacale D; Hofmeyr S; Ferrero A; Fuks D; Vibert E; Torzilli G; Scatton O; Brustia R;
Surgery; 2024 Feb; 175(2):413-423. PubMed ID: 37981553
[TBL] [Abstract][Full Text] [Related]
2. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
3. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Report of an international multicenter cohort study with propensity score matching.
Brustia R; Laurent A; Goumard C; Langella S; Cherqui D; Kawai T; Soubrane O; Cauchy F; Farges O; Menahem B; Hobeika C; Rhaiem R; Sommacale D; Okumura S; Hofmeyr S; Ferrero A; Pruvot FR; Regimbeau JM; Fuks D; Vibert E; Scatton O; ; ;
Surgery; 2022 May; 171(5):1290-1302. PubMed ID: 34535270
[TBL] [Abstract][Full Text] [Related]
4. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
[TBL] [Abstract][Full Text] [Related]
6. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
[TBL] [Abstract][Full Text] [Related]
8. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
9. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
Mukund A; V Srinivasan S; Rana S; Vijayaraghavan R; Patidar Y; Arora V; Jindal A; Choudhury A; Shasthry SM; Sarin SK
Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
13. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study.
Yang Z; Shi G
Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762
[TBL] [Abstract][Full Text] [Related]
16. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
18. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C
Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.
Kang SH; Choi Y; Lee W; Ahn S; Cho JY; Yoon YS; Han HS
Surg Oncol; 2020 Jun; 33():63-69. PubMed ID: 32561101
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]